Primary Ciliary DyskinesiaDiagnostics and screeningRare diseaseChildren's health
What this study is
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
What's being tested
- nNO testing
Intervention · OTHER
Collection of already performed clinical data and nNO testing
Study details
- Sponsor
- Vanderbilt University Medical Center
- Conditions
- Primary Ciliary Dyskinesia
- Enrolling
- 200 people
- Starts
- 2017-06-01
- Est. completion
- 2028-06-01
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 1 Year and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Referred to center for PCD diagnosis considerations
- Ability to perform study procedures
- Age greater than 2 years of age
You can't join if
- Age less than 2 years of age Inability to perform informed consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openVanderbilt Children's hospital
Nashville, Tennessee, United States
- Michael O'Connor, MD · Contact
Recruiting
Study team
Sponsor
Vanderbilt University Medical Center
Study ID IRB #160951
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.